Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$2.89 - $9.38 $2,641 - $8,573
914 New
914 $2,000
Q2 2023

Jul 18, 2023

BUY
$16.06 - $21.61 $5,604 - $7,541
349 New
349 $6,000
Q3 2022

Oct 26, 2022

SELL
$17.96 - $30.46 $16,038 - $27,200
-893 Reduced 94.0%
57 $1,000
Q2 2022

Jul 25, 2022

SELL
$10.26 - $23.59 $40,157 - $92,331
-3,914 Reduced 80.47%
950 $17,000
Q1 2022

May 02, 2022

BUY
$17.02 - $40.22 $8,850 - $20,914
520 Added 11.97%
4,864 $106,000
Q4 2021

Jan 28, 2022

BUY
$29.5 - $39.5 $128,148 - $171,588
4,344 New
4,344 $159,000

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $35.6M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.